Award supports independent investigators in hematology whose research confronts inequities in blood diseases amid shifting federal funding priorities (WASHINGTON, April 21, 2026) — In an effort to counteract federal cuts to health equity outcom...

Patients in sub-Saharan Africa less likely to know details about their disease variant, use over-the-counter medications, and go to the hospital for pain crises (WASHINGTON — Apr. 14, 2026) — Individuals living with sickle cell disease in sub-Sahara...

Recommendations outline best practices for preventing increasingly common, life-threatening complication in children (WASHINGTON, Apr. 8, 2026) — The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (IS...

The proposed 12.3% reduction in funding would impede progress in research for blood disorders (WASHINGTON—April 3, 2026) – The Trump Administration published details of the President’s Fiscal Year 2027 Budget Request, which include...

Recommendations outline best practices for diagnosing and managing the rare and life-threatening condition in children and adults (WASHINGTON — Apr. 1, 2026) — The American Society of Hematology (ASH) released guidelines on the diagnosis and manageme...

New data show 60% of sickle cell physicians report burnout (WASHINGTON — Mar. 12, 2026) — Hematology-oncology trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle c...

Findings could inform strategies to preserve blood cell health in athletes and stored blood (WASHINGTON – Feb. 18, 2026) – Extreme endurance running damages red blood cells in ways that may affect their ability to function properly, according to a s...

Recommendations outline optimal approaches to treating high-risk patient population, highlight need for additional research (WASHINGTON, Feb. 11, 2026) — The American Society of Hematology (ASH) released guidelines on frontline management of acute ly...

Recommendations outline best practices for diagnosing rare, complex bone marrow disorder (WASHINGTON — Jan. 28, 2026) — The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare...

Expanded ASH Scholar Award program supports early-career hematology researchers during critical transition period (WASHINGTON, January 22, 2026) — The American Society of Hematology (ASH) is awarding its 2026 Scholar Award to 53 early-career i...